@ARTICLE{
author={Chia Stephen KL,...,Holmes Frankie Ann,Ejlertsen Bent,Delaloge Suzette,Moy Beverly,Iwata Hiroji,von Minckwitz Gunter,Mansi Janine,Barrios Carlos H,Gnant Michael,Evic Zorica Toma,Denduluri Neelima,Eparovic Robert,Kim Sung-Bae,Jakobsen Erik Hugger,Harvey Vernon,Robert Nicholas,Smith John II,Harker Graydon,Lalani Alshad S,Zhang Bo,Eli Lisa D,Buyse Marc,(broj koautora 25)},
year={2018},
title={PIK3CA alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: Correlative analyses of the phase III ExteNET trial},
journal={CANCER RESEARCH},
volume={78},
number={4},
pages={-},
document_type={Meeting Abstract},
} 

